Table 2 Use of non-immunosuppressive drugs at baseline and 6 months after transplantation
Baseline (n = 44) | 6 months (n = 44) | p | |
|---|---|---|---|
Aspirin | 20 (45.5%) | 16 (36.4%) | 0.38 |
Calcium channel blockers | 14 (31.8%) | 16 (36.4%) | 0.65 |
Beta-blockers | 21 (47.7%) | 27 (61.4%) | 0.19 |
ARB/ACEi | 26 (60.5%) | 10 (22.7%) | 0.0001 |
Alpha-blockers | 7 (15.9%) | 8 (18.2%) | 0.77 |
Spironolactone | 1 (2.3%) | 1 (2.3%) | 1.0 |
Statin | 5 (11.4%) | 10 (22.7%) | 0.15 |
Ciprofibrate | 0 (0%) | 3 (6.8%) | 0.09 |
Furosemide | 17 (38.6%) | 2 (4.5%) | 0.001 |
Hydrochlorothiazide | 3 (6.8%) | 5 (11.4%) | 0.45 |
Isosorbide | 2 (4.5%) | 0 (0%) | 0.15 |